In the framework of « Investissements d’avenir » program (PIA), the Prime Minister Edouard Philippe has decided to prolong for another five years 103 LabEx (Laboratory of Excellence) following the« mid-course » evaluation by an international jury.
Following a positive evaluation based on its scientific results and the impact of its activities on the structuring of its 12 teams in a national network, the laboratory of Excellence Innovative Radiopharmaceuticals in Oncology and Neurology (LabEx IRON) has been extended to 5 years (2020-2024).
The LabEx IRON 2 will continue the implementation of ambitious and multi-disciplinary multi-partner projects integrating expertise from physics to medicine for the clinical transfer of innovative radiopharmaceuticals for PET imaging in oncology and neurology and molecular radiotherapy.